Greenleaf Trust Incyte Corp Transaction History
Greenleaf Trust
- $10.9 Billion
- Q4 2024
A detailed history of Greenleaf Trust transactions in Incyte Corp stock. As of the latest transaction made, Greenleaf Trust holds 5,066 shares of INCY stock, worth $343,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,066
Previous 4,849
4.48%
Holding current value
$343,778
Previous $320,000
9.06%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding INCY
# of Institutions
707Shares Held
189MCall Options Held
909KPut Options Held
489K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.09 Billion23.54% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.45 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.6MShares$1.33 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.01 Billion0.64% of portfolio
-
State Street Corp Boston, MA10MShares$681 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.1B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...